QV Bioelectronics

Electric field implants for brain cancer

Liverpool, UK

QV Bioelectronics focuses on therapeutic devices.

Shareable draft

Check out QV Bioelectronics on @MedStartr Today QV Bioelectronics focuses on therapeutic devices. #GlioblastomaGBM #BrainCancer #DiffuseMidlineGliomaDMG #MentalBehavioralHealth #MedicalDevices #MedMo #MedStartrVentures

https://www.medstartr.ai/s/VSGriF6OPP0

Get Involved in QV Bioelectronics

How We Help

Problem Statement

Aggressive brain cancers, such as glioblastoma (GBM) and diffuse midline glioma (DMG), have very low survival rates and limited effective treatment options.

Core Technology

Implantable Bioelectronics

Key Differentiators

Developing the GRACE implant for treating aggressive brain cancers.

Clinical Focus

Oncology; Neurosurgery

Company Info

Business Model: Hardware
Total Funding: Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now
Website: qvbio.co.uk/

Disease Areas

Glioblastoma (GBM)Brain Cancer Diffuse Midline Glioma (DMG)Mental Health

Technologies

Implantable DevicesBioelectronicsTherapeutic Devices

Clinical & IP

🔬

Clinical Validation

Breakthrough pre-clinical safety/efficacy results in large animal studies. FDA Breakthrough Device Designation. Positive FDA pre-submission feedback. First-in-human trials planned 2026. Published preclinical data: 3-month safety with no significant adverse events.

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of QV Bioelectronics?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.